Literature DB >> 9193852

Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia.

T M File1, J S Tan.   

Abstract

Determination of the etiologic pathogens of community-acquired pneumonia has been problematic because of the lack of reliable rapid laboratory diagnostic tools as well as the controversy concerning diagnostic criteria. In the studies reviewed here, a specific pathogen was identified in 39% to 88% of patients. Streptococcus pneumoniae remains the most common cause of community-acquired pneumonia. Depending on the demographics of the study, between 2% to 43% of cases have been attributed to legionella or Chlamydia pneumoniae. More recently, other pathogens have emerged, including respiratory syncytial virus in adults, hantavirus, and possibly legionella-like amoebal pathogens and Streptococcus milleri group. Treatment guidelines published by various societies of experts have been helpful, but they cannot replace the need for better and rapid diagnostic techniques.

Entities:  

Mesh:

Year:  1997        PMID: 9193852     DOI: 10.1097/00063198-199703000-00002

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  8 in total

1.  Clinical evaluation methods for new antimicrobial agents to treat respiratory infections: Report of the Committee for the Respiratory System, Japan Society of Chemotherapy.

Authors:  A. Saito; Fumio Miki; Kotaro Oizumi; Naoto Rikitomi; Akira Watanabe; Hironobu Koga; Yoshito Niki; Nobuchika Kusano
Journal:  J Infect Chemother       Date:  1999-06       Impact factor: 2.211

2.  Agreement between emergency physician diagnosis and radiologist reports in patients discharged from an emergency department with community-acquired pneumonia.

Authors:  Samuel G Campbell; Daphne D Murray; Ammar Hawass; David Urquhart; Stacy Ackroyd-Stolarz; David Maxwell
Journal:  Emerg Radiol       Date:  2005-06

3.  Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages.

Authors:  J S Braun; R Novak; G Gao; P J Murray; J L Shenep
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

4.  Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model.

Authors:  L De Hennezel; F Ramisse; P Binder; G Marchal; J M Alonso
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

5.  Streptococcus pneumoniae causing septic arthritis with shock and revealing multiple myeloma.

Authors:  Moussa Albert Riachy
Journal:  BMJ Case Rep       Date:  2011-05-24

6.  [Update to the Latin American Thoracic Association (ALAT) recommendations on community acquired pneumonia].

Authors: 
Journal:  Arch Bronconeumol       Date:  2004-08       Impact factor: 4.872

Review 7.  International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.

Authors:  Thomas M File; James S Tan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Comparison of Clarithromycin and Amoxicillin/Clavulanic Acid for Community-Acquired Pneumonia in an Era of Drug-Resistant Streptococcus pneumoniae.

Authors:  Pablo Bonvehi; Katherine Weber; Todd Busman; Dee Shortridge; Gerard Notario
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.